{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:33:44Z","timestamp":1786696424065,"version":"build-2736575974"},"reference-count":29,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Sarcoidosis is a granulomatous disease that can affect any organ but almost always involves the lungs (&gt;90%). Extrapulmonary involvement is frequent, particularly affecting the skin, eyes, and lymph nodes, while cardiac, kidney and neurological involvement may also occur. Evaluation and treatment can be complex and often require multidisciplinary collaboration. MRI and PET\/CT (with prolonged fasting) are key imaging tools in suspected cardiac sarcoidosis. Many patients do not need immunosuppressive therapy, but this review finds that methotrexate may be first-line therapy when long-term treatment is required.<\/jats:p>","DOI":"10.61409\/v12251071","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:41:57Z","timestamp":1782974517000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Sarcoidosis"],"prefix":"10.61409","author":[{"given":"Maria","family":"Stilling-Vinther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Salomonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wimmer-Aune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Bruun","family":"Kr\u00f8ig\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Kovacsne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Elberling","family":"Almasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref0","unstructured":"Dansk Lungemedicinsk Selskab. Sarkoidose, 2025. https:\/\/lungemedicin.dk\/sarkoidose (10. jan 2026)"},{"key":"ref1","unstructured":"Dansk Reumatologisk Selskab. National behandlingsvejledning sarkoidose, 2024. https:\/\/danskreumatologi.dk\/wp-content\/uploads\/2024\/01\/National-Behandlingsvejledning-Sarkoidose-til-hoering-002.pdf (10. jan 2026)"},{"key":"ref2","unstructured":"Dansk Cardiologisk Selskab. Kardiel sarkoidose og andre inflammatoriske kardiomyopatier: et holdningspapir fra Dansk Cardiologisk Selskab, 2024. https:\/\/www.cardio.dk\/media\/com_reditem\/files\/customfield\/item\/8150\/9ffb8ab9df2a402bf15d203faa426f5b0c19e0c9.pdf (10. jan 2026)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160(2):736-55. https:\/\/doi.org\/10.1164\/ajrccm.160.2.ats4-99","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Valeyre D, Jeny F, Rotenberg C et al. How to tackle the diagnosis and treatment in the diverse scenarios of extrapulmonary sarcoidosis. Adv Ther. 2021;38(9):4605-4627. https:\/\/doi.org\/10.1007\/s12325-021-01832-5","DOI":"10.1007\/s12325-021-01832-5"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Ghozy S, Revels JW, Sriwastwa A et al. Imaging in sarcoid disease. Best Pract Res Clin Rheumatol. 2025;39(3):102054. https:\/\/doi.org\/10.1016\/j.berh.2025.102054","DOI":"10.1016\/j.berh.2025.102054"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Spagnolo P, Bernardinello N. Sarcoidosis. Immunol Allergy Clin North Am. 2023;43(2):259-272. https:\/\/doi.org\/10.1016\/j.iac.2023.01.008","DOI":"10.1016\/j.iac.2023.01.008"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rossides M, Darlington P, Kullberg S, Arkema EV. Sarcoidosis: epidemiology and clinical insights. J Intern Med. 2023;293(6):668-680. https:\/\/doi.org\/10.1111\/joim.13629","DOI":"10.1111\/joim.13629"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Sikj\u00e6r MG, Hilberg O, Ibsen R, L\u00f8kke A. Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up. Respir Med. 2021;187:106548. https:\/\/doi.org\/10.1016\/j.rmed.2021.106548","DOI":"10.1016\/j.rmed.2021.106548"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Crouser ED, Maier LA, Wilson KC et al. Diagnosis and detection of sarcoidosis: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26-e51. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Savale L, Dorfm\u00fcller P, Boucly A et al. Sarcoidosis-associated pulmonary hypertension. Clin Chest Med. 2024;45(1):185-197. https:\/\/doi.org\/10.1016\/j.ccm.2023.08.007","DOI":"10.1016\/j.ccm.2023.08.007"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Spagnolo P, Kouranos V, Singh-Curry V et al. Extrapulmonary sarcoidosis. J Autoimmun. 2024;149:103323. https:\/\/doi.org\/10.1016\/j.jaut.2024.103323","DOI":"10.1016\/j.jaut.2024.103323"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Bechman K, Christidis D, Walsh S et al. A review of the musculoskeletal manifestations of sarcoidosis. Rheumatology (Oxford). 2018;57(5):777-783. https:\/\/doi.org\/10.1093\/rheumatology\/kex317","DOI":"10.1093\/rheumatology\/kex317"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Garret M, Pestronk A. Sarcoidosis, granulomas and myopathy syndromes: a clinical-pathology review. J Neuroimmunol. 2022;373:577975. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577975","DOI":"10.1016\/j.jneuroim.2022.577975"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Marcellis RGJ, Lenssen AF, Elfferich MDP et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J. 2011;38(3):628-34. https:\/\/doi.org\/10.1183\/09031936.00117710","DOI":"10.1183\/09031936.00117710"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"D\u00fcvel R, Marggraf V, Pizarro C et al. Glucocorticoid-induced adrenal insufficiency in sarcoidosis patients with long-term glucocorticoid therapy. Pneumologie. 2025;79(3):202-205. https:\/\/doi.org\/10.1055\/a-2510-9851","DOI":"10.1055\/a-2510-9851"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Aftab A, Szeto S, Aftab Z, Bokhari S. Cardiac sarcoidosis: diagnosis and management. Front Cardiovasc Med. 2024;11:1394075. https:\/\/doi.org\/10.3389\/fcvm.2024.1394075","DOI":"10.3389\/fcvm.2024.1394075"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mehta S, Lightle A, Judson MA. Renal sarcoidosis. Nephrol Dial Transplant. 2023;38(4):803-810. https:\/\/doi.org\/10.1093\/ndt\/gfac219","DOI":"10.1093\/ndt\/gfac219"},{"key":"ref18","unstructured":"Christensen PB, Yavarian Y, Holm I et al. Neurosarkoidose. Ugeskr L\u00e6ger. 2022;184(7):V09210704. https:\/\/ugeskriftet.dk\/videnskab\/neurosarkoidose"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"M\u00f8ller J, Hilberg O, Bendstrup E. Fatigue in patients with sarcoidosis in Denmark. Lung. 2023;201(1):103-110. https:\/\/doi.org\/10.1007\/s00408-023-00602-0","DOI":"10.1007\/s00408-023-00602-0"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Kraaijvanger R, Bon\u00e1s MJ, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11:1443. https:\/\/doi.org\/10.3389\/fimmu.2020.01443","DOI":"10.3389\/fimmu.2020.01443"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Spagnolo P, Dhanani Z, Cameli P et al. Advanced pulmonary sarcoidosis. Semin Respir Crit Care Med. 2025;46(6):564-575. https:\/\/doi.org\/10.1055\/a-2768-2520","DOI":"10.1055\/a-2768-2520"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Kovacsne A, Kr\u00f8igaard AB, Almasi CE, Stilling-Vinther M. Tiger man sign. Ugeskr L\u00e6ger. 2024;187:V74003. https:\/\/doi.org\/10.61409\/V74003","DOI":"10.61409\/V74003"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Lee H, Schubert EK, Vidula MK et al. Potential clinical utility of 68Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis. J Nucl Cardiol. 2023;30(3):1075-1087. https:\/\/doi.org\/10.1007\/s12350-022-03111-4","DOI":"10.1007\/s12350-022-03111-4"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Kronzer E, Hagan G, Ledet C et al. Updates in fluorodeoxyglucose positron emission tomography (18FDG-PET) in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2025;93:30-42. https:\/\/doi.org\/10.1016\/j.pcad.2025.08.004","DOI":"10.1016\/j.pcad.2025.08.004"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Shen Y, Yang Y. Comparing the diagnostic performance of [18F]FDG PET\/CT and [18F]FDG PET\/MRI for detecting cardiac sarcoidosis: a meta-analysis. Clin Imaging. 2024;113:110248. https:\/\/doi.org\/10.1016\/j.clinimag.2024.110248","DOI":"10.1016\/j.clinimag.2024.110248"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Baughman RP, Valeyre D, Korsten P et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6):2004079. https:\/\/doi.org\/10.1183\/13993003.04079-2020","DOI":"10.1183\/13993003.04079-2020"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Cremers JP, Drent M, Bast A et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med. 2013;19(5):545-61. https:\/\/doi.org\/10.1097\/MCP.0b013e3283642a7a","DOI":"10.1097\/MCP.0b013e3283642a7a"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Kahlmann V, Bon\u00e1s MJ, Moor CC et al. First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate. N Engl J Med. 2025;393(3):231-242. https:\/\/doi.org\/10.1056\/NEJMoa2501443","DOI":"10.1056\/NEJMoa2501443"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:21:24Z","timestamp":1786695684000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V12251071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.61409\/v12251071","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}